retatrutide type 2 diabetes phase 2 results 2024 ada Poster: Trends in Guideline-Directed Medical Therapy for in a Statewide Quality Collaborative Between 2018-2023 Pharmacological therapies for type 2

Research shows nearly half of people with type 2 diabetes stop taking GLP-1 drugs within a year due to factors like cost and side effects

Sing et al, 2024)

This two-tier validation system reassures researchers about the molecular identity, stability, and purity of the compound

As a proxy for heavy smoking (binary variable), we used diagnosis codes related to lung diseases highly associated with tobacco exposure along with diagnosis codes related to nicotine or tobacco, previous use of medications for the treatment of tobacco dependence, and initiation of drugs for obstructive airway disease after the age of 40

These medications include GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide, as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound)

Roll gently over each muscle group, focusing on areas that feel particularly tense